fda warning semaglutide warns about safety of 'off-brand' versions of Ozempic, Wegovy Semaglutide: The Drug of Today

When thyroid hormone levels are low, metabolism slows, leading to: Reduced resting energy expenditure: The body burns fewer calories even during basic functions Fluid retention: Hypothyroidism causes mucopolysaccharide accumulation in tissues, leading to a specific type of swelling called myxedema Fatigue and reduced activity: Low energy levels make consistent exercise challenging Altered appetite signaling: Thyroid hormones influence leptin sensitivity and appetite regulation Insulin resistance: Hypothyroidism is associated with impaired glucose metabolism, making fat storage more likely (Duntas & Brenta, 2018, Thyroid ) Even with adequate levothyroxine replacement, many hypothyroid patients report difficulty losing weight

Semaglutide's appetite-regulating effects make adhering to dietary changes less challenging, while the dietary component enhances the medication's effectiveness

You can verify this through your state board of pharmacy website

Semaglutide, liraglutide, and dulaglutide have demonstrated cardiovascular benefits in clinical trials, with Wegovy (semaglutide 2.4 mg) recently receiving FDA approval for cardiovascular risk reduction in adults with established cardiovascular disease and obesity